[1] 颜景祥,成立新,王春泉,等.曲美他嗪对PCI心肌损伤及术后再发心绞痛的影响[J].心血管康复医学杂志,2014,23(6):666.
[2] NDREPEPA G.Improving myocardial injury,infarct size,and myocardial salvage in the era of primary PCI for STEMI [J].Coron Artery Dis,2015,26(4):341.
[3] 裴芳,黄骥,黄婕.他汀类药物对UAP患者PCI术后心肌损伤与炎性因子的影响比较[J].重庆医学,2015,44(6):749.
[4] MANCHUROV V,RYAZANKINA N,KHMARA T,et al.Remote ischemic preconditioning and endothelial function in patients with acute myocardial infarction and primary PCI [J].Am J Med,2014,127(7):670.
[5] 吴钟伟,王圣,李斌,等.短期大剂量阿托伐他汀对PCI治疗不稳定型心绞痛患者炎症反应和心肌损伤的影响[J].山西医科大学学报,2015,46(4):293.
[6] 许晓晗,张维君,周玉杰,等.曲美他嗪对PCI术相关心肌损伤及术后再发心绞痛症状的临床研究[J].首都医科大学学报,2012,33(4):457.
[7] CUNG TT,MOREL O,CAYLA G,et al.Cyclosporine before PCI in Patients with Acute Myocardial Infarction [J].New EnglJ Med,2015,373(11):1021.
[8] 刘仁光,陈阳.心肌梗死与心电图诊断新标准[J].临床心电学杂志,2012,21(6):441.
[9] 赵庆丰,郝琳娟,杨乐,等.前列地尔对急性心肌梗死PCI术后的心肌保护作用[J].临床合理用药杂志,2015,8(31):19.
[10] JIAO Y,HU F,ZHANG Z,et al.Effect of rosuvastatin dose-loading on serum sLox-1,hs-CRP,and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI) [J].Int J Clin Exp Med,2015,8(11):21565.
[11] 盛建龙,王晓晨,许邦龙,等.负荷量瑞舒伐他汀对冠心病PCI术后预后的影响[J].安徽医药,2014,18(4):728.
[12] 毛积分,罗社文,黄建新,等.瑞舒伐他汀对不稳定型心绞痛患者PCI术后心肌损伤的保护作用[J].实用临床医药杂志,2014,18(3):12.
[13] FROHLICH GM,MEIER P,WHITE SK,et al.Myocardial reperfusion injury:looking beyond primary PCI [J].Eur Heart J,2013,34(23):1714.
[14] 陈磊,刘先霞,张远生.冠心病患者PCI手术围术期发生心肌损伤的相关因素分析[J].海南医学,2015,26(15):2218.
[15] 孙喜文,朱秀龙.不稳定型心绞痛患者应用曲美他嗪对PCI相关心肌损伤及左心室功能的影响[J].中华老年多器官疾病杂志,2016,15(1):42.